Fortitude Family Office’s AbbVie ABBV Stock Holding History

Fortitude Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	4,225 -26	-0.6%	-$5.59K	0.21%	67
2026 Q1	$925K	Sell	4,251 -1,257	-23%	-$279K	0.21%	67
2025 Q4	$1.26M	Sell	5,508 -36	-0.6%	-$8.2K	0.29%	65
2025 Q3	$1.28M	Sell	5,544 -386	-7%	-$78.6K	0.35%	58
2025 Q2	$1.1M	Sell	5,930 -1,717	-22%	-$319K	0.36%	53
2025 Q1	$1.6M	Sell	7,647 -2,703	-26%	-$525K	0.57%	31
2024 Q4	$1.84M	Buy	10,350 +91	+0.9%	+$16.7K	0.66%	30
2024 Q3	$2.03M	Buy	10,259 +6,162	+150%	+$1.15M	0.8%	25
2024 Q2	$703K	Buy	4,097 +2,364	+136%	+$392K	0.4%	39
2024 Q1	$316K	Hold	1,733	–	–	0.21%	64
2023 Q4	$269K	Buy	+1,733	New	+$253K	0.2%	70

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Fortitude Family Office's ABBV Position: Q2 2026 in Review

Fortitude Family Office reduced its AbbVie (ABBV) stake by 0.61% in Q2 2026, selling an estimated $5.59K and leaving 4,225 shares worth $1.06M. The position accounts for 0.21% of the portfolio, ranked #67.

Fortitude Family Office first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.03M in Q3 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fortitude Family Office held 4,225 shares of AbbVie worth $1.06M as of Q2 2026.
Fortitude Family Office sold 26 AbbVie shares in Q2 2026, an estimated $5.59K.
AbbVie made up 0.21% of Fortitude Family Office's portfolio in Q2 2026, its #67 holding.
Fortitude Family Office first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Fortitude Family Office's AbbVie position peaked at $2.03M in Q3 2024.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.